The interaction between methylene blue and the cholinergic system
Open Access
- 1 September 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (1) , 95-98
- https://doi.org/10.1038/sj.bjp.0701355
Abstract
1. The inhibitory effects of methylene blue (MB) on different types of cholinesterases and [3H]-N-methylscopolamine ([3H]-NMS) binding to muscarinic receptors were studied. 2. Human plasma from young healthy male volunteers, purified human pseudocholinesterase and purified bovine true acetylcholinesterase were incubated with acetylcholine and increasing concentrations of MB (0.1-100 mumol l-1) in the presence of the pH-indicator m-nitrophenol for 30 min at 25 degrees C. The amount of acetic acid produced by the enzymatic hydrolysis of acetylcholine was determined photometrically. 3. Rat cardiac left ventricle homogenate was incubated with [3H]-NMS and with increasing concentrations of MB (0.1 mmol l-1 mumol l-1) at 37 degrees C for 20 min. THe binding of [3H]-NMS to the homogenate was quantified by a standard liquid scintillation technique. 4. MB inhibited the esterase activity of human plasma, human pseudocholinesterase and bovine acetylcholinesterase concentration-dependently with IC50 values of 1.05 +/- 0.05 mumol l-1, 5.32 +/- 0.36 mumol l-1 and 0.42 +/- 0.09 mumol l-1, respectively. MB induced complete inhibition of the esterase activity of human plasma and human pseudocholinesterase, whereas bovine acetylcholinesterase was maximally inhibited by 73 +/- 3.3%. 5. MB was able to inhibit specific [3H]-NMS binding to rat cardiac left ventricle homogenate completely with an IC50 value of 0.77 +/- 0.03 mumol l-1, which resulted in a Ki value for MB of 0.58 +/- 0.02 mumol l-1. 6. In conclusion, MB may be considered as a cholinesterase inhibitor with additional, relevant affinity for muscarinic binding sites at concentrations at which MB is used for investigations into the endothelial system. In our opinion these interactions between MB and the cholinergic system invalidate the use of MB as a tool for the investigation of the L-arginine-NO-pathway, in particular when muscarinic receptor stimulation is involveKeywords
This publication has 13 references indexed in Scilit:
- In Vivo Characterization of Muscarinic Receptor Subtypes That Mediate Vasodilatation in Patients With Essential HypertensionHypertension, 1995
- A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate.The Journal of general physiology, 1995
- Cholinergic Receptor-Mediated Responses in the Arteriolar and Venous Vascular Beds of the Human ForearmBlood Pressure, 1995
- Inhibition of nitric oxide synthesis by methylene blueBiochemical Pharmacology, 1993
- Methylene blue inhibits neurogenic cholinergic vasodilator responses in the pulmonary vascular bed of the catAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1992
- Methylene blue and atresia or stenosis of ileum and jejunumThe Lancet, 1991
- Intestinal obstruction in babies exposed in utero to methylene blueThe Lancet, 1990
- Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin‐stimulated production of prostacyclin by pig aortic endothelial cellsBritish Journal of Pharmacology, 1989
- Oxidation of nitrogen oxides by bound dioxygen in hemoproteinsJournal of Inorganic Biochemistry, 1981
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976